We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rare and Undiagnosed Conditions Get Massive Research Funding Boost

News   Sep 25, 2018 | Original story from the National Institutes of Health

 
Rare and Undiagnosed Conditions Get Massive Research Funding Boost

Twelve clinical sites, a coordinating center, a sequencing core, a metabolomics core, two model organisms screening centers, and a central biorepository.

 
 
 

RELATED ARTICLES

Alzheimer's Risk Gene Impairs Brain's Immune Cells

News

A study carried out with a new human stem cell-derived model reveals that the most prevalent genetic risk factor of Alzheimer's disease (AD), apolipoprotein E4 (APOE4), impairs the function of human brain immune cells, microglia. These findings pave the way for new, effective treatment approaches for AD. The results were published in Stem Cell Reports.

READ MORE

Treating Blood Cancers With a Low-cost Arthritis Drug

News

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers, according to a new study by the University of Sheffield.

READ MORE

Transporting an Anti-cancer Agent to Cells Using Nanoparticles

News

Metal-organic frameworks (MOFs) could be used as a platform for delivering a potent anti-cancer agent, called siRNA, to cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE